Colorectal Cancer Trial, Recruiting NCT07148297 Sponsor: Epiliquid Holding, Inc Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07148297
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled to have a colonoscopy or colorectal surgery
  • People who are willing and able to give their informed consent to participate
  • People who are able to provide a blood and/or tissue sample before their treatment or surgery

Who may not be able to join:

  • People who have a previous history of colorectal cancer
  • People who have inflammatory bowel disease
  • People with a known inherited cancer syndrome, such as Lynch syndrome or FAP (familial adenomatous polyposis)
  • People who currently have another active cancer
  • People who have recently received chemotherapy or medication that suppresses the immune system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +5492616603254

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Epiliquid Holding, Inc
Registry
ClinicalTrials.gov
Start date
30 June 2021
Est. completion
1 August 2025

Where this trial is recruiting

🇦🇷 Argentina

Primary endpoints

Sensitivity and Specificity of delta-HLD Technology for Colorectal Cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov